Compile Data Set for Download or QSAR
maximum 50k data
Found 453 with Last Name = 'ishizaka' and Initial = 't'
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260242(US9522914, A-44)
Affinity DataIC50:  0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260242(US9522914, A-44)
Affinity DataIC50:  0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222831(CHEMBL401132 | N-(5-tert-butyl-3-(cyclopropylmethy...)
Affinity DataIC50:  0.410nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260267(US9522914, B-20)
Affinity DataIC50:  0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260267(US9522914, B-20)
Affinity DataIC50:  0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260241(US9522914, A-43)
Affinity DataIC50:  0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260241(US9522914, A-43)
Affinity DataIC50:  0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222845(CHEMBL247830 | N-(5-tert-butyl-3-(cyclopropylmethy...)
Affinity DataIC50:  0.5nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260347(US9522914, D-36)
Affinity DataIC50:  0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260347(US9522914, D-36)
Affinity DataIC50:  0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM21311(4-(2-{3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]...)
Affinity DataIC50:  0.770nMAssay Description:Binding affinity to CB2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)
Affinity DataIC50:  0.820nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260206(US9522914, A-08)
Affinity DataIC50:  0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260206(US9522914, A-08)
Affinity DataIC50:  0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)
Affinity DataIC50:  0.820nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260237(US9522914, A-39)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260237(US9522914, A-39)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50375384(CHEMBL263913)
Affinity DataIC50:  1.10nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222841((Z)-3-bromo-N-(5-tert-butyl-3-(cyclopropylmethyl)-...)
Affinity DataIC50:  1.20nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222834(CHEMBL398713 | N-(5-tert-butyl-3-(cyclopropylmethy...)
Affinity DataIC50:  1.20nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50375382(CHEMBL410014)
Affinity DataIC50:  1.40nMAssay Description:Displacement of [3H]CP-55940 from CB1 receptor in Sprague-Dawley rat spleen membraneMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260248(US9522914, B-01)
Affinity DataIC50:  1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260248(US9522914, B-01)
Affinity DataIC50:  1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260264(US9522914, B-17)
Affinity DataIC50:  1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260264(US9522914, B-17)
Affinity DataIC50:  1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260329(US9522914, D-18)
Affinity DataIC50:  1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260329(US9522914, D-18)
Affinity DataIC50:  1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50375385(CHEMBL264154)
Affinity DataIC50:  1.70nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222832(CHEMBL248386 | N-(5-tert-butyl-3-(cyclopropylmethy...)
Affinity DataIC50:  2.10nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)
Affinity DataIC50:  2.10nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)
Affinity DataIC50:  2.10nMAssay Description:Displacement of [3H]CP-55940 form human CB1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222833(CHEMBL555610 | N-(5-tert-butyl-3-(cyclopropylmethy...)
Affinity DataIC50:  2.10nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260308(US9522914, C-19)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260256(US9522914, B-09)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260256(US9522914, B-09)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260249(US9522914, B-02)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260308(US9522914, C-19)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260249(US9522914, B-02)
Affinity DataIC50:  2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50222844(CHEMBL248015 | N-(5-tert-butyl-3-(2-ethoxyethyl)-4...)
Affinity DataIC50:  2.30nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260213(US9522914, A-15)
Affinity DataIC50:  2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260213(US9522914, A-15)
Affinity DataIC50:  2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260316(US9522914, D-05)
Affinity DataIC50:  2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260316(US9522914, D-05)
Affinity DataIC50:  2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260220(US9522914, A-22)
Affinity DataIC50:  2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260220(US9522914, A-22)
Affinity DataIC50:  2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50375383(CHEMBL440407)
Affinity DataIC50:  2.60nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260352(US9522914, D-41)
Affinity DataIC50:  2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260352(US9522914, D-41)
Affinity DataIC50:  2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260255(US9522914, B-08)
Affinity DataIC50:  2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
Taisho Pharmaceutical

US Patent
LigandPNGBDBM260341(US9522914, D-30)
Affinity DataIC50:  2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 453 total ) | Next | Last >>
Jump to: